Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of the multi-centre study is to evaluate correctly the impact of three dimensional visualization on operation strategy and complications for Pancreatic Cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 18, 2017
CompletedFirst Submitted
Initial submission to the registry
November 19, 2018
CompletedFirst Posted
Study publicly available on registry
November 21, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2020
CompletedNovember 21, 2018
April 1, 2018
3 years
November 19, 2018
November 19, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact on operation strategy of three dimensional visualization technique
Firstly, the operation strategies based on original CT or MRI image data will be made by the team, Secondly, the operation strategies based on three dimensional reconstruction models will be made by the team, then, actually surgical strategies will be recorded. The change of operation strategy will be assessed by comparing the strategy of the 2D model and 3D model. The change rate of operation strategy will be recorded and presented as percentage.
30 days
Secondary Outcomes (2)
Impact on complication of three dimensional visualization technique
30 days
1-year disease free survival rate
12 months
Eligibility Criteria
The patients with Pancreatic Cancer.
You may qualify if:
- years≤ Age ≤70 years 2.Compling with the diagnosis criteria of Pancreatic Cancer. 3.Primary Pancreatic Cancer without metastasis. 4.The patients are volunteered for the study.
You may not qualify if:
- Patients with mental illness.
- Patients can't tolerate the operation owe to a variety of basic diseases (such as severe cardiopulmonary insufficiency, renal insufficiency, cachexia and blood system diseases, etc.)
- The patients refused to take part in the study.
- There are other co-existed malignant tumors.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zhujiang Hospital of The Southern Medical University
Guangzhou, Guangdong, 510282, China
Related Publications (2)
Wu X, Wang D, Xiang N, Pan M, Jia F, Yang J, Fang C. Augmented reality-assisted navigation system contributes to better intraoperative and short-time outcomes of laparoscopic pancreaticoduodenectomy: a retrospective cohort study. Int J Surg. 2023 Sep 1;109(9):2598-2607. doi: 10.1097/JS9.0000000000000536.
PMID: 37338535DERIVEDTao H, Zeng X, Lin W, Wang Z, Lin J, Li J, Qian Y, Yang J, Fang C. Indocyanine green fluorescence imaging to localize insulinoma and provide three-dimensional demarcation for laparoscopic enucleation: a retrospective single-arm cohort study. Int J Surg. 2023 Apr 1;109(4):821-828. doi: 10.1097/JS9.0000000000000319.
PMID: 37026828DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2018
First Posted
November 21, 2018
Study Start
April 18, 2017
Primary Completion
April 30, 2020
Study Completion
August 30, 2020
Last Updated
November 21, 2018
Record last verified: 2018-04